Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics

Cell Chemical Biology
Salvador GuardiolaErnest Giralt

Abstract

Prolyl oligopeptidase (POP), a serine protease highly expressed in the brain, has recently emerged as an enticing therapeutic target for the treatment of cognitive and neurodegenerative disorders. However, most reported inhibitors suffer from short duration of action, poor protease selectivity, and low blood-brain barrier (BBB) permeability, which altogether limit their potential as drugs. Here, we describe the structure-based design of the first irreversible, selective, and brain-permeable POP inhibitors. At low-nanomolar concentrations, these covalent peptidomimetics produce a fast, specific, and sustained inactivation of POP, both in vitro and in human cells. More importantly, they are >1,000-fold selective against two family-related proteases (DPPIV and FAP) and display high BBB permeability, as shown in both lipid membranes and MDCK cells.

Citations

Jul 20, 2018·Angewandte Chemie·Pablo Martín-Gago, Christian A Olsen
Sep 26, 2019·Current Protein & Peptide Science·Anna J Kiss-SzemánDóra K Menyhárd
Apr 7, 2020·Journal of Biomolecular Structure & Dynamics·Shweta SharmaMymoona Akhter
Aug 23, 2019·Nature Communications·Ruting XuSaihu Liao
Jul 4, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Arduino A MangoniPaula A C Gomes
Apr 2, 2019·Journal of Biomolecular Structure & Dynamics·Apeksha ShrivastavaMymoona Akhter
Dec 10, 2019·Journal of Biomolecular Structure & Dynamics·Shweta SharmaMymoona Akhter
May 21, 2020·Biochimica Et Biophysica Acta. General Subjects·Yakov E DunaevskyElena N Elpidina
Apr 27, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Apoorva M KulkarniKeun Woo Lee
Jun 9, 2021·ChemMedChem·Fabian H KnaupFelix Hausch
Jul 30, 2021·Frontiers in Pharmacology·Jasmin GattringerRoland Hellinger
Aug 6, 2021·Chemical Science·Tao ZhongJiang Weng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
K D MullenA J McCullough
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Shinsuke Nakagawa, Masami Niwa
© 2022 Meta ULC. All rights reserved